News | February 03, 2015

Study Shows Grafting Surgery Provides Better Value than Angioplasty

Research examines costs and quality of life benefits of two common heart procedures

ASCERT, coronary bypass graft surgery, angioplasty, quality of life, value

February 3, 2015 — Coronary bypass graft surgery commonly used to treat patients with coronary heart disease results in improved quality of life but also costs more than another often-used less invasive technique, Christiana Care Health System researchers reported in January in the Journal of the American College of Cardiology.

Known as the ASCERT (American College of Cardiology Foundation–The Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies) study, this research represents the first of its kind nationwide to evaluate and compare hundreds of thousands of clinical and claims data to determine both the survival benefit and overall costs of coronary artery bypass graft compared to percutaneous coronary intervention, another common surgical procedure that is also referred to as angioplasty.

The study found that patients who underwent bypass graft surgery lived longer and were able to function better and had less additional procedures than those treated with angioplasty. Researchers drew their conclusions by analyzing a widely-accepted metric known as quality-adjusted life-years.

“While other studies have compared the costs of the two types of treatment, we wanted to probe deeper to understand the value of these procedures to patients,” said Zugui Zhang, Ph.D., a senior biostatistician and scholar at Christiana Care’s Value Institute, and lead author in the study. “Although the grafting procedure costs more, we also found that patients who underwent that procedure lived longer and had fewer additional procedures.”

Over a four-year period, the study looked at people 65 years or older with coronary heart disease in two or three of their heart vessels.

In addition to the quality of life metrics, researchers found the grafting procedure also resulted in higher costs per patient than angioplasty in three areas:

  • Hospitalization was on average $10,670 more.
  • Clinical care after the surgery was on average $8,145 more.
  • Lifetime projected costs after the surgery were on average $11,575 more.

 

“Coronary heart disease affects so many of our neighbors, so our hope is to provide patients and their families with knowledge so they can make informed decisions on their health care,” Zhang said. “Through this study, we have found that coronary artery bypass grafts provide a reasonably better value to patients when compared to angioplasties.”

For more information: www.christianacare.org

Related Content

Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
Overlay Init